ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMPL Impel Pharmaceuticals Inc

0.2411
0.00 (0.00%)
Last Updated: 10:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 577k1.76M2.8M3.08M5.01M4.37M6.58M5.02M
Operating Income -24.25M-22.72M-20.98M-21.24M-18.24M-24.44M-16.1M-12.81M
Pre Tax Income -24.74M-26.97M-25.2M-31.1M-23.04M-30.07M-7.36M-13.81M
Net Income -24.61M-26.97M-25.2M-31.1M-23.04M-30.07M-7.36M-13.81M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -24.74M-22.54M-21.57M-27.91M-20.28M-27.13M-7.04M-10.15M
EBITDA -23.94M-22.41M-20.69M-20.94M-17.94M-24.16M-16.16M-12.18M
Year End 31 December 2022 2019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00668k12.65M
Operating Income -41.57M-45.33M-71.49M-83.18M
Pre Tax Income -41.83M-45.8M-76.53M-106.31M
Net Income -41.86M-45.8M-76.54M-106.31M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -116.275-60.66-3.31-4.478
EBIT -42.25M-45.74M-76.53M-92.48M
EBITDA -40.84M-44.26M-70.4M-81.98M

Your Recent History

Delayed Upgrade Clock